MF
Insider
Meghan Fitzgerald
DirectorMeghan Fitzgerald (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $1.9M of ROIV (70,000 sh × $27.45, as filed), executed Mar 26.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.3M
shares × price, as filed
Last traded
Sep 15
Filed Sep 17
Median ADV $222.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
ROIVRecent filings
ROIVSALE
Roivant Sciences Ltd.
View filing →
$187K4,712 sh × $39.68
Exec Sep 15
Filed Sep 17 · 6:42 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $798K
20,000 sh × $39.90
Exec Sep 8
Filed Sep 10 · 9:00 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $349K
10,000 sh × $34.90
Exec Jun 30
Filed Jul 2 · 7:03 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $1.9M
70,000 sh × $27.45
Exec Mar 26
Filed Mar 30 · 5:30 PM ET